HQY Strangle Strategy
HQY (HealthEquity, Inc.), in the Healthcare sector, (Medical - Healthcare Information Services industry), listed on NASDAQ.
Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States. The company provides cloud-based solutions designed to assist individuals in overseeing their healthcare expenditures and savings. These platforms enable users to make informed decisions about their health finances, pay medical bills, compare treatment options and costs, access personalized benefits and clinical data, earn incentives for wellness, and grow their savings through various investment avenues, including specific investment choices. In addition to these personal financial management tools, HealthEquity administers a range of health-related accounts, such as Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). Its offerings also encompass a mutual fund investment platform, an automated online advisory service known as Advisor, COBRA continuation services, and the management of pre-tax commuter benefits programs. HealthEquity markets its services through a dedicated direct sales team, collaborates with benefits brokers and advisors, and leverages a comprehensive network comprising health plans, benefits administrators, consultants, and retirement plan record-keepers.
HQY (HealthEquity, Inc.) trades in the Healthcare sector, specifically Medical - Healthcare Information Services, with a market capitalization of approximately $8.82B, a trailing P/E of 38.60, a beta of 0.21 versus the broader market, a 52-week range of 72.76-107.62, average daily share volume of 928K, a public-listing history dating back to 2014, approximately 3K full-time employees. These structural characteristics shape how HQY stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.21 indicates HQY has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 38.60 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a strangle on HQY?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
HQY snapshot
As of August 14, 2026, spot at $105.25, ATM IV 41.60%, IV rank 4.52%, expected move 11.93%. The strangle on HQY below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this strangle structure on HQY specifically: HQY IV at 41.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a HQY strangle, with a market-implied 1-standard-deviation move of approximately 11.93% (roughly $12.55 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated HQY expiries trade a higher absolute premium for lower per-day decay. Position sizing on HQY should anchor to the underlying notional of $105.25 per share and to the trader's directional view on HQY stock.
HQY strangle setup
The HQY strangle below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With HQY at $105.25 on that close, the first option leg uses a $110.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed HQY chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 HQY shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $110.00 | $3.65 |
| Buy 1 | Put | $100.00 | $3.20 |
HQY strangle risk and reward
- Net Premium / Debit
- -$685.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$685.00
- Breakeven(s)
- $93.15, $116.85
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
HQY strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on HQY. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$9,314.00 |
| $23.28 | -77.9% | +$6,986.97 |
| $46.55 | -55.8% | +$4,659.95 |
| $69.82 | -33.7% | +$2,332.92 |
| $93.09 | -11.6% | +$5.90 |
| $116.36 | +10.6% | -$48.87 |
| $139.63 | +32.7% | +$2,278.15 |
| $162.90 | +54.8% | +$4,605.18 |
| $186.17 | +76.9% | +$6,932.20 |
| $209.44 | +99.0% | +$9,259.23 |
When traders use strangle on HQY
Strangles on HQY are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the HQY chain.
HQY thesis for this strangle
The market-implied 1-standard-deviation range for HQY extends from approximately $92.70 on the downside to $117.80 on the upside. A HQY long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current HQY IV rank near 4.52% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on HQY at 41.60%. As a Healthcare name, HQY options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to HQY-specific events.
HQY strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. HQY positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move HQY alongside the broader basket even when HQY-specific fundamentals are unchanged. Always rebuild the position from current HQY chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on HQY?
- A strangle on HQY is the strangle strategy applied to HQY (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With HQY stock at $105.25 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed HQY chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are HQY strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the HQY strangle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 41.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$685.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a HQY strangle?
- The breakeven for the HQY strangle priced on this page is roughly $93.15 and $116.85 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The HQY market-implied 1-standard-deviation expected move in the same options snapshot is approximately 11.93%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on HQY?
- Strangles on HQY are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the HQY chain.
- How does current HQY implied volatility affect this strangle?
- HQY ATM IV is at 41.60% with IV rank near 4.52%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.